Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Pyatyorochka chain entered the Tyva Republic

12/26/24 X5

VTB acquired the Labinsky agricultural complex

12/26/24 VTBR

VTB reported for 11 months of 2024 by IFRS

12/26/24 VTBR

Delimobile introduced the possibility of car buyback

12/26/24 DELI

Moscow Exchange will resume morning trading on the stock and derivatives markets

12/25/24 MOEX

Rosatom, Sergey Shishkarev and Transmashholding to merge logistics assets

12/25/24 FESH

Smile of the rainbow opened a beauty-format store in the center of St. Petersburg

12/25/24 LENT

Fesco's container fleet crossed the 200 thousand TEU mark

12/25/24 FESH

Henderson's revenue for 11 months grew 23.7%

12/25/24 HNFG

Cherkizovo builds two poultry complexes in the Bryansk region

12/25/24 GCHE